Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zoetis Australia is a leading animal health company that develops and manufactures a wide range of medicines, vaccines, and diagnostic products for livestock and companion animals. As the Australian subsidiary of the global Zoetis Inc., it provides critical solutions for veterinarians and producers across species including cattle, sheep, pigs, dogs, and cats. Their portfolio includes innovative monoclonal antibodies for pain and dermatology, as well as established vaccine and anti-infective brands. The company maintains a strong local presence with manufacturing and R&D capabilities focused on the unique needs of the Australian agricultural and veterinary sectors. Key products include the Apoquel and Cytopoint dermatology range and the Simparica parasiticide line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zoetis Australia.